Ursodeoxycholic acid in primary sclerosing cholangitis: meta‐analysis of randomized controlled trials
- 27 August 2009
- journal article
- Published by Wiley in Hepatology Research
- Vol. 39 (9), 865-873
- https://doi.org/10.1111/j.1872-034x.2009.00527.x
Abstract
The effect of ursodeoxycholic acid (UDCA) treatment on survival and liver histological progression of primary sclerosing cholangitis (PSC) remains uncertain. The aim of the present study was to evaluate the effect and safety of UDCA in PSC. Electronic databases including Medline, Embase, Cochrane controlled trials register, Web of Science and PubMed (updated to January 2009) and manual bibliographical searches were carried out. A meta-analysis of all randomized controlled trials (RCT) comparing UDCA with placebo or no treatment was carried out. Eight RCT including 465 patients were assessed. UDCA could significantly improve liver biochemistry, but had no effect on pruritus and fatigue. Meta-analysis of the included RCT showed UDCA had no significant effect on the incidence of death, liver transplantation, and death and/or liver transplantation. However, a significant difference for the incidence of histological improvement was found between the two groups (odds ratio [OR], 9.19; 95% CI: 0.98, 86.15; P = 0.05). Meta-analysis also indicated a reduction trend of histological deterioration and an improvement trend of cholangiographic changes. These trends were constant in the sensitivity analyses. The meta-analysis found that UDCA can improve liver biochemistry and there is a trend towards improvement in liver histology and cholangiography, but has no effect on survival free of transplantation.Keywords
This publication has 22 references indexed in Scilit:
- Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitisHepatology, 2004
- Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing CholangitisAmerican Journal Of Gastroenterology, 2004
- Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisitedHepatology, 2002
- Management of Primary Sclerosing CholangitisAmerican Journal Of Gastroenterology, 2002
- A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitisGastroenterology, 2001
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodJournal of Hepatology, 1994
- Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trialHepatology, 1992
- Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acidGastroenterology, 1990
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990